Lv4
500 积分 2022-03-13 加入
Novel therapies for acute myeloid leukemia. Does age still matter?
1个月前
已完结
How I manage mantle cell lymphoma: indolent versus aggressive disease
1个月前
已完结
Frontline treatment of adults with newly diagnosed B-cell acute lymphoblastic leukaemia
2个月前
已完结
Up-front blinatumomab improves MRD clearance and outcome in adult Ph– B-lineage ALL: the GIMEMA LAL2317 phase 2 study
3个月前
已完结
Monoclonal Gammopathy of Renal Significance
3个月前
已完结
Systemic Light Chain Amyloidosis
3个月前
已完结
Venetoclax plus ‘2 + 5’ modified intensive chemotherapy with daunorubicin and cytarabine in fit elderly patients with untreated de novo acute myeloid leukaemia: a single‐centre retrospective analysis
4个月前
已完结
Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial
4个月前
已完结
Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial
4个月前
已关闭
Incidence, mortality, and survival associated with acute leukaemia subtypes by age group in China: a population-based cancer registry analysis and cohort study
5个月前
已完结
皖公网安备34019202002308
